Novel TAF Subdermal Implant for the Prevention and Treatment of HIV/AIDS (IMAGE)

Oak Crest Institute of Science

Novel TAF Subdermal Implant for the Prevention and Treatment of HIV/AIDS

Caption

The novel, subdermal implant, developed by scientists from the Oak Crest Institute of Science, provides sustained release of potent antiretroviral drugs which are showing extreme promise in preventing sexually transmitted HIV when used as pre-exposure prophylaxis.

Credit

Photos by Gunawardana, M and Remedios-Chan, M.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.